May. 14 at 12:43 PM
$IFRX I recently saw a report on “RTL Aktuell”, a German news program, about ME/CFS and it immediately made me think about InflaRx. Of course this is only my personal thought. With ME/CFS, people are now discussing possible issues involving the immune system, inflammation and the complement system, which is exactly the area InflaRx has been focusing on for years with C5a. At the same time, neurological issues, energy metabolism and circulation/microcirculation problems are also being considered. GOHIBIC already received regulatory recognition for COVID-ARDS, another condition where strong immune and inflammatory reactions play a major role. I understand this does not mean InflaRx would automatically work in ME/CFS or is even working on it. But from a general scientific point of view, I find the possible overlap at least interesting.
https://cfc.charite.de/fuer_patienten/
https://www.bundesgesundheitsministerium.de/service/publikationen/details/myalgische-enzephalomyelitis-chronic-fatigue-syndrome-me-cfs
